Company profile: Intelect Medical
1.1 - Company Overview
Company description
- Provider of implantable neuromodulation systems and deep brain stimulation (DBS) therapies and technology for recovery from stroke and traumatic brain injury.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Intelect Medical
Embrella Cardiovascular
HQ: United States
Website
- Description: Provider of a medical device system to enhance embolic cerebral protection, helping interventionalists reduce the frequency of embolic strokes during cardiovascular procedures; based in Malvern, Pennsylvania.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Embrella Cardiovascular company profile →
VeriNOS Pharma
HQ: Germany
Website
- Description: Provider of innovative therapeutics under clinical development for cerebral diseases, focusing on traumatic brain injury. Develops drugs inhibiting a defined cascade. Product Ronopterin, a selective iNOS inhibitor, reduces brain damage and improves outcomes in traumatic brain injury, neuro-oncology, and diabetic retinopathy by decreasing glutamate and radical production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VeriNOS Pharma company profile →
JuvLabs
HQ: Isle of Man
Website
- Description: Provider of biotech therapies and products to modify aging and address age-related diseases. Through its JuvRx therapeutics division, the company develops novel treatments targeting fibrosis and inflammatory conditions, including serpin-based PAI-1 inhibitors, TGF-β modulation drugs, NAD+ metabolism enhancers (with the Buck Institute), ketone-based therapies for heart failure, and an oral plasmalogen precursor to restore cell function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full JuvLabs company profile →
Axsome Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for neurological disorders, including Auvelity for major depressive disorder and Sunosi to improve wakefulness in adults with excessive daytime sleepiness due to obstructive sleep apnea or narcolepsy; developing AXS-05 for Alzheimer’s disease agitation and smoking cessation, AXS-07 for acute migraine, and AXS-12 for narcolepsy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axsome Therapeutics company profile →
CereVasc
HQ: United States
Website
- Description: Provider of endovascular medical devices for treating hydrocephalus, including the eShunt System—an endovascularly implantable cerebrospinal fluid shunt with delivery components designed to treat communicating hydrocephalus without invasive surgery—and a portfolio of follow-on product concepts to improve care for neurovascular diseases, including therapies deliverable across the blood-brain barrier.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CereVasc company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Intelect Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Intelect Medical
2.2 - Growth funds investing in similar companies to Intelect Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Intelect Medical
4.2 - Public trading comparable groups for Intelect Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →